BYDUREON Receives Marketing Authorization in Europe (LLY) (ALKS) (AMLN)
Go back to BYDUREON Receives Marketing Authorization in Europe (LLY) (ALKS) (AMLN)| ALKERMES (NASDAQ: ALKS) | Delayed: 48.02 -2.16 (4.3%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.18 | 52 Week High | $80.71 | |||
| Open | $49.37 | 52 Week Low | $27.14 | |||
| Day High | $49.86 | P/E | 369.38 | |||
| Day Low | $47.93 | EPS | $0.13 | |||
| Volume | 1,635,208 | |||||
| Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) | Delayed: 30.98 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.98 | 52 Week High | $31.02 | |||
| Open | $3.30 | 52 Week Low | $8.03 | |||
| Day High | $30.98 | P/E | N/A | |||
| Day Low | $30.98 | EPS | $-4.38 | |||
| Volume | 440,704 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1244.40 -35.94 (2.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1280.34 | 52 Week High | $88.16 | |||
| Open | $1274.13 | 52 Week Low | $67.88 | |||
| Day High | $1280.28 | P/E | 288.06 | |||
| Day Low | $1243.23 | EPS | $4.32 | |||
| Volume | 2,621,172 | |||||
